These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23019670)

  • 1. Fighting the resistance: rejuvenating anticancer platinum-based drugs.
    O'Hare A
    Nanomedicine (Lond); 2012 Jul; 7(7):947-8. PubMed ID: 23019670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fighting the resistance: rejuvenating anticancer platinum-based drugs.
    O'Hare A
    Future Med Chem; 2012 Jul; 4(11):1380. PubMed ID: 23029699
    [No Abstract]   [Full Text] [Related]  

  • 3. Combating the drug resistance of cisplatin using a platinum prodrug based delivery system.
    Min Y; Mao CQ; Chen S; Ma G; Wang J; Liu Y
    Angew Chem Int Ed Engl; 2012 Jul; 51(27):6742-7. PubMed ID: 22639083
    [No Abstract]   [Full Text] [Related]  

  • 4. Delivering a photosensitive transplatin prodrug to overcome cisplatin drug resistance.
    Song H; Li W; Qi R; Yan L; Jing X; Zheng M; Xiao H
    Chem Commun (Camb); 2015 Jul; 51(57):11493-5. PubMed ID: 26094840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Approaches to Platinum(IV) Prodrugs: A Variety of Strategies for Enhanced Delivery and Efficacy.
    Najjar A; Rajabi N; Karaman R
    Curr Pharm Des; 2017; 23(16):2366-2376. PubMed ID: 28155621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-casein and its complexes with chitosan as nanovehicles for delivery of a platinum anticancer drug.
    Razmi M; Divsalar A; Saboury AA; Izadi Z; Haertlé T; Mansuri-Torshizi H
    Colloids Surf B Biointerfaces; 2013 Dec; 112():362-7. PubMed ID: 24028849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prodrugs in combination with nanocarriers as a strategy for promoting antitumoral efficiency.
    Lin MH; Hung CF; Hsu CY; Lin ZC; Fang JY
    Future Med Chem; 2019 Aug; 11(16):2131-2150. PubMed ID: 31538520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.
    Luo C; Sun J; Sun B; He Z
    Trends Pharmacol Sci; 2014 Nov; 35(11):556-66. PubMed ID: 25441774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gold nanorods for platinum based prodrug delivery.
    Min Y; Mao C; Xu D; Wang J; Liu Y
    Chem Commun (Camb); 2010 Nov; 46(44):8424-6. PubMed ID: 20936244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells.
    Garmann D; Warnecke A; Kalayda GV; Kratz F; Jaehde U
    J Control Release; 2008 Oct; 131(2):100-6. PubMed ID: 18691617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An H₂O₂-responsive nanocarrier for dual-release of platinum anticancer drugs and O₂: controlled release and enhanced cytotoxicity against cisplatin resistant cancer cells.
    Chen H; He W; Guo Z
    Chem Commun (Camb); 2014 Sep; 50(68):9714-7. PubMed ID: 25017175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.
    Johnstone TC; Suntharalingam K; Lippard SJ
    Chem Rev; 2016 Mar; 116(5):3436-86. PubMed ID: 26865551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug transporters of platinum-based anticancer agents and their clinical significance.
    Burger H; Loos WJ; Eechoute K; Verweij J; Mathijssen RH; Wiemer EA
    Drug Resist Updat; 2011 Feb; 14(1):22-34. PubMed ID: 21251871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Iron Oxide Nanocarrier Loaded with a Pt(IV) Prodrug and Immunostimulatory dsRNA for Combining Complementary Cancer Killing Effects.
    Hernández-Gil J; Cobaleda-Siles M; Zabaleta A; Salassa L; Calvo J; Mareque-Rivas JC
    Adv Healthc Mater; 2015 May; 4(7):1034-42. PubMed ID: 25846677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
    Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
    Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient co-delivery of a Pt(IV) prodrug and a p53 activator to enhance the anticancer activity of cisplatin.
    Ma R; Wang Y; Yan L; Ma L; Wang Z; Chan HC; Chiu SK; Chen X; Zhu G
    Chem Commun (Camb); 2015 May; 51(37):7859-62. PubMed ID: 25854514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted polysaccharide nanoparticle for adamplatin prodrug delivery.
    Yang Y; Zhang YM; Chen Y; Chen JT; Liu Y
    J Med Chem; 2013 Dec; 56(23):9725-36. PubMed ID: 24252070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Drug Delivery System for Platinum-based Anticancer Drugs.
    Gao C; Zhang Y; Chen J; Wang T; Qian Y; Yang B; Dong P; Zhang Y
    Mini Rev Med Chem; 2016; 16(11):872-91. PubMed ID: 26586124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platinum(iv) prodrugs with long lipid chains for drug delivery and overcoming cisplatin resistance.
    Chen Q; Yang Y; Lin X; Ma W; Chen G; Li W; Wang X; Yu Z
    Chem Commun (Camb); 2018 May; 54(42):5369-5372. PubMed ID: 29744485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclodextrin capped gold nanoparticles as a delivery vehicle for a prodrug of cisplatin.
    Shi Y; Goodisman J; Dabrowiak JC
    Inorg Chem; 2013 Aug; 52(16):9418-26. PubMed ID: 23889547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.